oral glp 1 agonist for type 2 diabetes Small-Molecule GLP-1 Receptor Agonists: Mechanistic Insights and Emerging Therapeutic Strategies The current significance and prospects

References U.S

N Engl J Med 2025;392:777-87.ArticlePubMed 118

Randomized 52-week phase 2 trial of albiglutide versus placebo in adult patients with newly diagnosed type 1 diabetes

Fieldhouse writes that it preferentially targets the production of cyclic adenosine monophosphate and notes that, in a recent clinical trial, 92.8% of the participants lost at least 5% of their body weight

Maximizing Your Tax Savings With GLP-1 Treatment If you carry a high-deductible health plan (HDHP) and fund an HSA, GLP-1 medications represent one of the largest ongoing qualified medical expenses you can pay with pre-tax dollars

Chen S, Yu SJ, Li Y, et al